Ginkgo

A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats.

DSpace/Manakin Repository

Müller, Nora; van den Brandt, Jens; Odoardi, Francesca; Tischner, Denise; Herath, Judith; Flügel, Alexander; Reichardt, Holger M. (2008): A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats. - The Journal of clinical investigation; Vol. 118, No. 4, p. 1405-1416.

Verlinken Sie auf bzw. zitieren Sie dieses Dokument mit der folgenden permanenten URL:
bookmark http://resolver.sub.uni-goettingen.de/purl?gs-1/6254

Files in this item

Files Size Format Beschreibung Version
documentvan den Brandt.pdf 1.286Mb PDF Keine Beschreibung publishedVersion
 
 
Web of Science® Times Cited:29

Verlagspublikation: 10.1172/JCI32698

 
Author: Müller, Nora; van den Brandt, Jens; Odoardi, Francesca; Tischner, Denise; Herath, Judith; Flügel, Alexander; Reichardt, Holger M.
Abstract: Administration of the CD28 superagonistic antibody JJ316 is an efficient means to treat autoimmune diseases in rats, but the humanized antibody TGN1412 caused devastating side effects in healthy volunteers during a clinical trial. Here we show that JJ316 treatment of rats induced a dramatic redistribution of T lymphocytes from the periphery to the secondary lymphoid organs, resulting in severe T lymphopenia. Live imaging of secondary lymphoid organs revealed that JJ316 administration almost instantaneously (<2 minutes) arrested T cells in situ. This reduction in T cell motility was accompanied by profound cytoskeletal rearrangements and increased cell size. In addition, surface expression of lymphocyte function-associated antigen-1 was enhanced, endothelial differentiation sphingolipid G protein-coupled receptor 1 and L selectin levels were downregulated, and the cells lost their responsiveness to sphingosine 1-phosphate-directed migration. These proadhesive alterations were accompanied by signs of strong activation, including upregulation of CD25, CD69, CD134, and proinflammatory mediators. However, this did not lead to a cytokine storm similar to the clinical trial. While most of the early changes disappeared within 48 hours, we observed that CD4+CD25+FoxP3+ regulatory T cells experienced a second phase of activation, which resulted in massive cell enlargement, extensive polarization, and increased motility. These data suggest that CD28 superagonists elicit 2 qualitatively distinct waves of activation.
URI: http://resolver.sub.uni-goettingen.de/purl?gs-1/6254
Date: 2008

The following license files are associated with this item:

Share on:

This item appears in the following Collection(s)

Show full item record

Search DSpace

Advanced Search

Browse

My Account

Infos & Hilfe


Login: ?

GWDG-Benutzername ist der Namensteil uname von ihrer E-Mail-Adresse uname@gwdg.de oder uname@med.uni-goettingen.de

Das Passwort ist Ihr Passwort bei der GWDG.